225 related articles for article (PubMed ID: 15605986)
1. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions.
Dalfó E; Albasanz JL; Martin M; Ferrer I
Brain Pathol; 2004 Oct; 14(4):388-98. PubMed ID: 15605986
[TBL] [Abstract][Full Text] [Related]
2. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL; Dalfó E; Ferrer I; Martín M
Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex.
Rodríguez A; Freixes M; Dalfó E; Martín M; Puig B; Ferrer I
Neuroscience; 2005; 131(4):825-32. PubMed ID: 15749337
[TBL] [Abstract][Full Text] [Related]
4. Abnormal group I metabotropic glutamate receptor expression and signaling in the frontal cortex in Pick disease.
Dalfó E; Albasanz JL; Rodríguez A; Martín M; Ferrer I
J Neuropathol Exp Neurol; 2005 Jul; 64(7):638-47. PubMed ID: 16042316
[TBL] [Abstract][Full Text] [Related]
5. Glial involvement in diffuse Lewy body disease.
Terada S; Ishizu H; Yokota O; Tsuchiya K; Nakashima H; Ishihara T; Fujita D; Uéda K; Ikeda K; Kuroda S
Acta Neuropathol; 2003 Feb; 105(2):163-9. PubMed ID: 12536227
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
[TBL] [Abstract][Full Text] [Related]
7. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.
Piao YS; Wakabayashi K; Hayashi S; Yoshimoto M; Takahashi H
Clin Neuropathol; 2000; 19(4):163-9. PubMed ID: 10919347
[TBL] [Abstract][Full Text] [Related]
8. Metabotropic glutamate receptor/phospholipase C system in female rat heart.
Iglesias I; Castillo CA; León D; Ruíz MA; Albasanz JL; Martín M
Brain Res; 2007 Jun; 1153():1-11. PubMed ID: 17493590
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic gestational treatment with caffeine or theophylline on Group I metabotropic glutamate receptors in maternal and fetal brain.
León D; Albasanz JL; Ruíz MA; Iglesias I; Martín M
J Neurochem; 2005 Jul; 94(2):440-51. PubMed ID: 15998294
[TBL] [Abstract][Full Text] [Related]
10. Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology.
Lewis KA; Su Y; Jou O; Ritchie C; Foong C; Hynan LS; White CL; Thomas PJ; Hatanpaa KJ
Am J Pathol; 2010 Dec; 177(6):3037-50. PubMed ID: 21056999
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains.
Kawamoto Y; Akiguchi I; Nakamura S; Honjyo Y; Shibasaki H; Budka H
J Neuropathol Exp Neurol; 2002 Mar; 61(3):245-53. PubMed ID: 11895039
[TBL] [Abstract][Full Text] [Related]
12. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM
J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371
[TBL] [Abstract][Full Text] [Related]
15. Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
Dalfó E; Portero-Otín M; Ayala V; Martínez A; Pamplona R; Ferrer I
J Neuropathol Exp Neurol; 2005 Sep; 64(9):816-30. PubMed ID: 16141792
[TBL] [Abstract][Full Text] [Related]
16. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
17. Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments.
Jensen PH; Islam K; Kenney J; Nielsen MS; Power J; Gai WP
J Biol Chem; 2000 Jul; 275(28):21500-7. PubMed ID: 10764738
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 4,5-bisphosphate modifies tubulin participation in phospholipase Cbeta1 signaling.
Popova JS; Greene AK; Wang J; Rasenick MM
J Neurosci; 2002 Mar; 22(5):1668-78. PubMed ID: 11880496
[TBL] [Abstract][Full Text] [Related]
19. Diffuse Lewy body disease.
Kosaka K
Neuropathology; 2000 Sep; 20 Suppl():S73-8. PubMed ID: 11037193
[TBL] [Abstract][Full Text] [Related]
20. Group I metabotropic glutamate receptors elicit epileptiform discharges in the hippocampus through PLCbeta1 signaling.
Chuang SC; Bianchi R; Kim D; Shin HS; Wong RK
J Neurosci; 2001 Aug; 21(16):6387-94. PubMed ID: 11487662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
